638 Characterisation of the immune response to EO2401, a new immunotherapy approach against cancer, plus nivolumab in recurrent glioblastoma: The EOGBM1–18/ROSALIE study
Ana Maia, Hélène Toussaint, Joao Gamelas Magalhaes, Ahmed Idbaih, Maria Vieito Villar, Ghazaleh Tabatabai, Agostina Stradella, Francois Ghiringhelli, Michael C Burger, Iris Mildenberger, Ulrich Herrlinger, Macarena González, Alice Hervieu, Marta GilMartin, Mirjam Renovanz, Mehdi Touat, Patrick Wen, Antje Wick, Christophe Bonny, Jean-Michel Paillarse, David Reardon, Wolfgang Wick, Cécile Gouttefangeas
Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A730; DOI: 10.1136/jitc-2023-SITC2023.0638